cicaprost   Click here for help

GtoPdb Ligand ID: 1917

Synonyms: ZK 96480 | ZK-96480
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Cicaprost is an orally active, synthetic prostacyclin (PGI2) analogue. It produces anti-platelet and vasodilatory effects in vivo [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 3
Rotatable bonds 6
Topological polar surface area 86.99
Molecular weight 374.21
XLogP 1.89
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCC#CCC(C(C#CC1C(O)CC2C1CC(=CCOCC(=O)O)C2)O)C
Isomeric SMILES CCC#CC[C@@H]([C@@H](C#C[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C/COCC(=O)O)/C2)O)C
InChI InChI=1S/C22H30O5/c1-3-4-5-6-15(2)20(23)8-7-18-19-12-16(9-10-27-14-22(25)26)11-17(19)13-21(18)24/h9,15,17-21,23-24H,3,6,10-14H2,1-2H3,(H,25,26)/b16-9+/t15-,17-,18+,19-,20+,21+/m0/s1
InChI Key ARUGKOZUKWAXDS-SEWALLKFSA-N
References
1. Abramovitz M, Adam M, Boie Y, Carrière M, Denis D, Godbout C, Lamontagne S, Rochette C, Sawyer N, Tremblay NM et al.. (2000)
The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs.
Biochim Biophys Acta, 1483 (2): 285-93. [PMID:10634944]
2. Belch JJ, McLaren M, Lau CS, Mackay IR, Bancroft A, McEwen J, Thompson JM. (1993)
Cicaprost, an orally active prostacyclin analogue: its effects on platelet aggregation and skin blood flow in normal volunteers.
Br J Clin Pharmacol, 35 (6): 643-7. [PMID:8329292]
3. Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Sugimoto Y, Narumiya S. (1997)
Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
Br J Pharmacol, 122 (2): 217-24. [PMID:9313928]
4. Wang JW, Vu C, Poloso NJ. (2017)
A Prostacyclin Analog, Cicaprost, Exhibits Potent Anti-Inflammatory Activity in Human Primary Immune Cells and a Uveitis Model.
J Ocul Pharmacol Ther, 33 (3): 186-192. [PMID:28072560]